If you need more lookups,
subscriptions start at $34 USD/month.
Ross McKinnon Location
Adelaide, SA, AU
Ross McKinnon Work
2017 -now Matthew Flinders Distinguished Professor @
2012 -2022 Beat Cancer Professor (Supported by Cancer Council SA) @
2019 -2020 Foundation Director, Flinders Health and Medical Research Institute @
2017 -2020 Dean (Research), College of Medicine and Public Health @
2012 -2017 Inaugural Director, Flinders Centre for Innovation in Cancer @
2014 -2017 Associate Dean, Research @
2011 -2012 Research Director @
2012 -now Adjunct Professor @
2017 -now Board Member @
2016 -now Chair, Scientific Advisory Panel @
1983 -now Pharmacist @
2020 -2024 Chair, Board of Pharmaceutical Sciences @
2011 -2020 Adjunct Professor @
2001 -2011 Professor @
2005 -2009 Director, Sansom Institute @
2005 -2009 Associate Head of School (Research) @
2004 -2005 Director, Centre for Pharmaceutical Research (CPR) @
1995 -2001 Lecturer and Senior Lecturer and Associate Professor @
2012 -2019 Vice President @
2010 -2014 Chair, 5th Pharmaceutical Sciences World Congress @
2007 -2018 Director @
2010 -2010 National Facilitator, Translating Health Discovery SuperScience project @ DIISR
now Principal Scientist @ PharmaQest
now President @ Australasian Pharmaceutical Science Association
1993 -1995 NHMRC CJ Martin Fellow @
1993 -1993 Research Assistant @
1987 -1988 Pharmacist @ Wimmera Base Hospital
1983 -1987 Pharmacist and Senior Pharmacist @
Ross McKinnon Education
Flinders University
PhD (Pharmacology)
1989-1993
Flinders University
B Sci (Hons) (Pharmacology)
1988-1988
South Australian Institute of Technology
B Pharm (Pharmacy)
1979-1982
Ross McKinnon Summary
Ross McKinnon, based in Adelaide, SA, AU, is currently a Matthew Flinders Distinguished Professor at Flinders University. Ross McKinnon brings experience from previous roles at Flinders University. Ross McKinnon holds a 1989 - 1993 PhD in Pharmacology @ Flinders University. Ross McKinnon has 3 emails on RocketReach.
Looking for a different Ross McKinnon?
Find contact details for 700 million professionals.